-
公开(公告)号:US20100190780A1
公开(公告)日:2010-07-29
申请号:US12703112
申请日:2010-02-09
申请人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-LLobet
发明人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-LLobet
IPC分类号: A61K31/541 , C07D413/12 , A61K31/5377 , C07D231/22 , A61K31/415 , C07D403/12 , C07D401/12 , A61K31/454 , A61K31/4178 , C07D471/04 , A61K31/437 , A61K31/496 , A61K31/4725 , C07D417/12 , A61P1/12 , A61P3/04 , A61P9/06 , A61P9/12 , A61P25/28 , A61P25/06 , A61P25/30 , A61P25/32 , A61P25/34 , A61P25/36 , A61P25/14 , A61P9/10 , A61P25/08 , A61P35/00 , A61P25/22 , A61P25/24 , A61P25/18 , A61P29/00 , A61P37/06
CPC分类号: C07D471/04 , C07D231/22 , C07D401/12 , C07D403/12
摘要: The invention relates to compounds of formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved.
摘要翻译: 本发明涉及具有对σ受体的药理学活性的式(I)化合物,这些化合物的制备方法,包含它们的药物组合物及其用于治疗和/或预防其中σ受体 参与。
-
公开(公告)号:US08314096B2
公开(公告)日:2012-11-20
申请号:US12703126
申请日:2010-02-09
申请人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
发明人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
IPC分类号: A61K31/4152 , A61K31/4155 , A61K31/5375 , A61K31/5377
CPC分类号: A61K31/415 , A61K31/4178 , A61K31/437 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/541
摘要: The invention relates to compounds of formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved.
-
公开(公告)号:US08293740B2
公开(公告)日:2012-10-23
申请号:US12703114
申请日:2010-02-09
申请人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
发明人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
IPC分类号: A61K31/5377 , A61K31/4155 , C07D231/22 , C07D413/12
CPC分类号: A61K31/415 , A61K31/4178 , A61K31/437 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/541
摘要: The invention relates to compounds of formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved.
摘要翻译: 本发明涉及具有对σ受体的药理学活性的式(I)化合物,这些化合物的制备方法,包含它们的药物组合物及其用于治疗和/或预防其中σ受体 参与。
-
4.
公开(公告)号:USRE38963E1
公开(公告)日:2006-01-31
申请号:US10229880
申请日:1999-05-27
申请人: Maria Rosa Cuberes-Altisent , Juana Maria Berrocal-Romero , Maria Montserrat-Contijoch-Llobet , Jordi Frigola-Constansa
发明人: Maria Rosa Cuberes-Altisent , Juana Maria Berrocal-Romero , Maria Montserrat-Contijoch-Llobet , Jordi Frigola-Constansa
IPC分类号: C07D231/06 , A61K31/41
CPC分类号: C07D231/06
摘要: The present invention relates to new pyazoline derivatives of formula and to physiologically acceptable salts thereof, to the method for their preparation and to their application as medicaments.
摘要翻译: 本发明涉及式的新的吡唑啉衍生物及其生理上可接受的盐,其制备方法及其作为药物的应用。
-
公开(公告)号:US20100190781A1
公开(公告)日:2010-07-29
申请号:US12703126
申请日:2010-02-09
申请人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
发明人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
IPC分类号: A61K31/541 , A61K31/5377 , A61K31/437 , A61K31/496 , A61K31/4725 , A61K31/415 , A61K31/454 , A61K31/4178 , A61P9/06 , A61P1/12 , A61P3/04 , A61P9/12 , A61P25/28 , A61P25/06 , A61P25/30 , A61P25/32 , A61P25/34 , A61P25/36 , A61P25/14 , A61P9/10 , A61P25/08 , A61P35/00 , A61P25/24 , A61P25/22 , A61P25/18 , A61P29/00 , A61P37/06
CPC分类号: A61K31/415 , A61K31/4178 , A61K31/437 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/541
摘要: The invention relates to compounds of formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved.
-
公开(公告)号:US5849931A
公开(公告)日:1998-12-15
申请号:US875806
申请日:1997-08-05
申请人: Jordi Frigola-Constansa , Juana Maria Berrocal Romero , Maria Rosa Cuberes Altisent , Vicente Gotor Santamaria
发明人: Jordi Frigola-Constansa , Juana Maria Berrocal Romero , Maria Rosa Cuberes Altisent , Vicente Gotor Santamaria
IPC分类号: C07D231/12
CPC分类号: C07D231/12
摘要: A method for predominantly preparing the enantiomer (R)-(+)-5-(phenyl)hydroxymethyl-1-methyl-1H-pyrazole, (R)-(+)-1, by separating the racemate (+)-5-(phenyl)hydroxymethyl-1-methyl-1H-pyrazole of formula (1), comprising the series of steps of using a lipase or material derived therefrom having enzymatic activity in a transesterification reaction, as well as hydrolysing the resulting ester, (S)-(-)-5-(phenyl)alkylcarbonyloxymethyl-1-methyl-1H-pyrazole, of formula (S)-(-)-4, wherein R.sub.1 is a methyl or ethyl radical.
摘要翻译: PCT No.PCT / EP96 / 05596 Sec。 371日期:1997年8月5日 102(e)日期1997年8月5日PCT 1997年12月4日PCT PCT。 出版物WO97 / 20817 日期:1997年6月12日主要通过将外消旋体(R) - (+) - ( - ) - (+) - +) - 5-(苯基)羟甲基-1-甲基-1H-吡唑,其包括使用脂肪酶或其衍生的物质在酯交换反应中具有酶活性的一系列步骤,以及水解所得 酯,(S) - ( - ) - ( - ) - ( - ) - 5-(苯基)烷基羰基氧基甲基-1-甲基-1H-吡唑,其中R1是甲基或乙基。
-
公开(公告)号:US20100190790A1
公开(公告)日:2010-07-29
申请号:US12703114
申请日:2010-02-09
申请人: Christian LAGGNER , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
发明人: Christian LAGGNER , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
IPC分类号: A61K31/5377 , C07D413/12 , A61P1/12 , A61P3/04 , A61P9/12 , A61P1/04 , A61P9/06 , A61P19/02 , A61P25/06 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/30 , A61P25/32 , A61P25/34 , A61P25/36 , A61P25/28 , A61P25/14 , A61P9/10 , A61P35/00
CPC分类号: A61K31/415 , A61K31/4178 , A61K31/437 , A61K31/454 , A61K31/4725 , A61K31/496 , A61K31/5377 , A61K31/541
摘要: The invention relates to compounds of formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved.
-
公开(公告)号:US20080125416A1
公开(公告)日:2008-05-29
申请号:US11574361
申请日:2005-08-29
申请人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
发明人: Christian Laggner , Maria Rosa Cuberes-Altisent , Joerg Holenz , Juana Maria Berrocal-Romero , Maria Montserrat Contijoch-Llobet
IPC分类号: C07D231/18 , C07D413/02 , A61K31/5377 , C07D401/02 , A61K31/495 , A61K31/541 , A61P9/00 , A61P35/00 , A61P25/00 , C07D417/02 , A61K31/4725 , A61K31/454 , C07D403/02 , A61K31/415
CPC分类号: C07D471/04 , C07D231/22 , C07D401/12 , C07D403/12
摘要: The invention relates to compounds of formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved.
摘要翻译: 本发明涉及具有对σ受体的药理学活性的式(I)化合物,这些化合物的制备方法,包含它们的药物组合物及其用于治疗和/或预防其中σ受体 参与。
-
-
-
-
-
-
-